Marco Aveggio Merello
Director/Miembro de la Junta en Grupo Wiese .
Perfil
Marco Aveggio Merello has worked as a Director at Grupo Wiese and ZEV Biotech.
Cargos activos de Marco Aveggio Merello
| Empresas | Cargo | Inicio |
|---|---|---|
Grupo Wiese
 Grupo Wiese Financial ConglomeratesFinance Grupo Wiese operates as a group of companies that provides investment management services. Its service portfolio includes real estate, shipping, financial, insurance, and logistics sector. The company was founded by Augusto Wiese Eslava and is headquartered in Lima 27, Peru. | Director/Miembro de la Junta | - |
ZEV Biotech
 ZEV Biotech Medical SpecialtiesHealth Technology ZEV Biotech is an Argentinean biotechnology company that specializes in molecular diagnostic kits for hereditary and infectious diseases, as well as pharmacogenomics of polar iris medicines technology. The company is based in Buenos Aires, Argentina. The company's technology is easy and cost-effective to implement in any laboratory, hospital, clinic, or other health institutions, both public and private, and adapts to the requirements of each one. The company was founded in 2014 by Maximiliano Irisarri, who has been the CEO since 2014. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Grupo Wiese
Grupo Wiese Financial ConglomeratesFinance Grupo Wiese operates as a group of companies that provides investment management services. Its service portfolio includes real estate, shipping, financial, insurance, and logistics sector. The company was founded by Augusto Wiese Eslava and is headquartered in Lima 27, Peru. | Finance |
ZEV Biotech
ZEV Biotech Medical SpecialtiesHealth Technology ZEV Biotech is an Argentinean biotechnology company that specializes in molecular diagnostic kits for hereditary and infectious diseases, as well as pharmacogenomics of polar iris medicines technology. The company is based in Buenos Aires, Argentina. The company's technology is easy and cost-effective to implement in any laboratory, hospital, clinic, or other health institutions, both public and private, and adapts to the requirements of each one. The company was founded in 2014 by Maximiliano Irisarri, who has been the CEO since 2014. | Health Technology |
- Bolsa de valores
- Insiders
- Marco Aveggio Merello
